StockTipsArenaBeta

BUY Dr. Reddy's Laboratories Limited — Jigar S Patel, Anand Rathi

BUYDr. Reddy's Laboratories Limited
Dr. Reddy's Laboratories share price target & all analyst calls

byJigar S Patel, Anand RathiHorizon: NA (inferred Swing (≤2wk))20 Jul 2026via ET Now

Entry₹1,230Inferred
Target₹1,400
Total upside +13.82% (call closed)
Stop loss₹1,140-7.32% risk
Exit₹1,14023 Jul 2026, 9:15 am
Stop-loss hit-7.32%
Follow Jigar S Patel for new calls(14% target hit, 50 closed calls)Get alertsWatch DRREDDY for new buy/sell callsGet alertsSee 4 active Swing calls on DRREDDYSee 149 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 23 Jul 2026
0 supporting3 neutral3 opposing
Supports the BUY call (0)

Nothing found in this tip’s window yet.

Neutral / worth noting (3)

Dr. Reddy's Laboratories Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

NSE · Outcome of Board Meeting·22 Jul · today

(opens in new tab)

Dr. Reddy's Laboratories will release its Q1FY27 financial results on Wednesday, July 22nd, 2026. An earnings call is scheduled for the same day to discuss financial performance.

NSE · Press Release·13 Jul · 1w ago

(opens in new tab)

Dr. Reddy's Laboratories will announce its Q1FY27 financial results on Wednesday, July 22nd, 2026, followed by an earnings call at 19:30 PM IST.

BSE · Company Update·13 Jul · 1w ago

(opens in new tab)
Weighs against the BUY call (3)

Dr. Reddy's Laboratories shares will react to weak Q1 after US-listed ADR falls 10%

NewsCnbc-Tv18·23 Jul · today

(opens in new tab)

Dr Reddy's Q1 Results: Semaglutide API provision weighs on profit; margin halves

NewsCnbc-Tv18·22 Jul · today

(opens in new tab)

1 advisor has an active short-term SELL call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·9 Jul · 2w ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Dr. Reddy's Laboratories

All analyst calls on Dr. Reddy's Laboratories

More from Jigar S Patel, Anand Rathi

Every call and its outcome